Trial intelligence / Profile preview

PENG Block for Surgical Stress and Analgesia in Total Hip Arthroplasty

NCT07023107Phase 4Completed

Sponsor
Poznan University of Medical Sciences
Start
Jun 2025
Primary completion
Dec 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of ropivacaine in hip arthropathy, hip osteoarthritis, chronic hip pain, sponsored by Poznan University of Medical Sciences. Started Jun 2025; status: completed.

02

Drugs

ropivacaine
03

Conditions

hip arthropathyhip osteoarthritischronic hip pain

Beyond the preview

Go deeper on NCT07023107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07023107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call